公开(公告)号：US20080064717A1

公开(公告)日：2008-03-13

申请号：US11749952

申请日：2007-05-17

申请人： Rajesh Iyengar ,  Gang Zhao ,  Jennifer Freeman ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  John Lynch ,  Mathew Mulhern ,  Andrew Souers

发明人： Rajesh Iyengar ,  Gang Zhao ,  Jennifer Freeman ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  John Lynch ,  Mathew Mulhern ,  Andrew Souers

IPC分类号： A61K31/4402 ,  A61K31/17 ,  A61K31/19 ,  A61P3/00 ,  C07C61/06 ,  C07D471/04 ,  C07D213/46 ,  C07C275/28 ,  A61P1/16 ,  A61K31/4375

CPC分类号： C07C335/22 ,  C07C229/46 ,  C07C275/30 ,  C07C275/32 ,  C07C275/38 ,  C07C279/28 ,  C07C2601/08 ,  C07C2601/14 ,  C07D213/55 ,  C07D213/75 ,  C07D277/30 ,  C07D333/22 ,  C07D333/36 ,  C07D401/04 ,  C07D401/12 ,  C07D409/12 ,  C07D409/14

摘要： The present invention relates to compounds of formula (I): wherein R1, R3, X, Q, Z, A, 9, m, and n are defined herein Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.

摘要翻译： 本发明涉及式（I）化合物：其中R 1，R 3，X，Q，Z，A，9，m和n如本文所定义 还公开了治疗DGAT-1相关疾病或病症的药物组合物和方法。

公开(公告)号：US20050137187A1

公开(公告)日：2005-06-23

申请号：US10744571

申请日：2003-12-23

申请人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Dariusz Wodka

发明人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Dariusz Wodka

IPC分类号： A61K31/416 ,  A61K31/454 ,  A61K31/55 ,  C07D231/56 ,  C07D401/06 ,  C07D403/06 ,  C07D405/12 ,  C07D491/10 ,  C07D43/02

CPC分类号： C07D401/06 ,  A61K31/416 ,  A61K31/454 ,  A61K31/55 ,  C07D231/56 ,  C07D403/06 ,  C07D405/12 ,  C07D491/10

摘要： The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

摘要翻译： 本发明涉及黑色素浓缩激素（MCH）通过黑色素浓缩激素受体的作用的拮抗作用，其可用于预防或治疗进食障碍，体重增加，肥胖，生殖和性行为异常，甲状腺激素 分泌，利尿和水/电解质体内平衡，感觉加工，记忆，睡眠，唤醒，焦虑，抑郁，癫痫发作，神经变性和精神疾病。

公开(公告)号：US20050277638A1

公开(公告)日：2005-12-15

申请号：US11022453

申请日：2004-12-22

申请人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Dariusz Wodka

发明人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Dariusz Wodka

IPC分类号： A61K31/416 ,  A61K31/5377 ,  C07D231/56 ,  C07D401/04 ,  C07D401/06 ,  C07D403/06 ,  C07D403/14 ,  C07D405/12 ,  C07D409/04 ,  C07D409/12 ,  C07D413/02 ,  C07D413/04

CPC分类号： C07D403/14 ,  C07D231/56 ,  C07D401/04 ,  C07D401/06 ,  C07D403/06 ,  C07D405/12 ,  C07D409/04 ,  C07D409/12 ,  C07D413/04

摘要： The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

公开(公告)号：US20050209274A1

公开(公告)日：2005-09-22

申请号：US11065918

申请日：2005-02-25

申请人： John Lynch ,  Christine Collins ,  Jennifer Freeman ,  Ju Gao ,  Rajesh Iyengar ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Andrew Souers ,  Gang Zhao ,  Dariusz Wodka

发明人： John Lynch ,  Christine Collins ,  Jennifer Freeman ,  Ju Gao ,  Rajesh Iyengar ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Andrew Souers ,  Gang Zhao ,  Dariusz Wodka

IPC分类号： A61K31/452 ,  A61K31/4709 ,  C07D405/12 ,  C07D405/14 ,  C07D409/14 ,  C07D413/14 ,  C07D417/14 ,  C07D45/02

CPC分类号： C07D417/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/14 ,  C07D413/14

摘要： The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

公开(公告)号：US20050187387A1

公开(公告)日：2005-08-25

申请号：US10787694

申请日：2004-02-25

申请人： John Lynch ,  Christine Collins ,  Jennifer Freeman ,  Ju Gao ,  Rajesh Iyengar ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Andrew Souers ,  Gang Zhao

发明人： John Lynch ,  Christine Collins ,  Jennifer Freeman ,  Ju Gao ,  Rajesh Iyengar ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Andrew Souers ,  Gang Zhao

IPC分类号： B32B27/02 ,  C07D401/12 ,  C07D405/12 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14

CPC分类号： C07D405/12 ,  C07D401/12 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14

摘要： The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

摘要翻译： 本发明涉及通过黑色素浓缩激素受体拮抗黑色素浓缩激素（MCH）的作用的式（I）化合物，其可用于预防或治疗进食障碍，体重增加，肥胖症，异常 生殖和性行为，甲状腺激素分泌，利尿和水/电解质体内平衡，感觉加工，记忆，睡眠，觉醒，焦虑，抑郁，癫痫发作，神经变性和精神疾病。

公开(公告)号：US20050187279A1

公开(公告)日：2005-08-25

申请号：US11020464

申请日：2004-12-22

申请人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Dariusz Wodka

发明人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Dariusz Wodka

IPC分类号： C07D231/56 ,  C07D401/06 ,  C07D403/04 ,  C07D403/06 ,  C07D405/06 ,  C07D491/10 ,  A61K31/416

CPC分类号： C07D403/06 ,  C07D231/56 ,  C07D401/06 ,  C07D403/04 ,  C07D405/06 ,  C07D491/10

摘要： The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

公开(公告)号：US20050137243A1

公开(公告)日：2005-06-23

申请号：US10744188

申请日：2003-12-23

申请人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Anil Vasudevan ,  Dariusz Wodka

发明人： Andrew Souers ,  Christine Collins ,  Ju Gao ,  Andrew Judd ,  Philip Kym ,  Mathew Mulhern ,  Hing Sham ,  Anil Vasudevan ,  Dariusz Wodka

IPC分类号： C07D231/56 ,  C07D401/04 ,  C07D401/12 ,  C07D403/06 ,  C07D403/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  A61K31/416

CPC分类号： C07D413/12 ,  C07D231/56 ,  C07D401/04 ,  C07D401/12 ,  C07D403/06 ,  C07D403/12 ,  C07D405/12 ,  C07D409/12

摘要： The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.